Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer

This study has been completed.
Information provided by (Responsible Party):
Swiss Group for Clinical Cancer Research Identifier:
First received: March 8, 2002
Last updated: May 14, 2012
Last verified: May 2012